Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amrutanjan Health CareBOM:590006 -0.70%71 Days Inventory is 62.79 as of Jun. 2026, which is 33% above its 10-year median of 47.09. GuruFocus rates BOM:590006 with a GF Score™ of 71/100 and a GF Value™ of ₹827.69 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Amrutanjan Health Care ranks better than 94.46% on this metric.
The historical rank and industry rank for Amrutanjan Health Care's Days Inventory or its related term are showing as below:
BOM:590006'
s Days Inventory Range Over the Past 10 Years
Min: 38.27 Med: 47.09 Max: 59.69
Current: 48.87
During the past 13 years, Amrutanjan Health Care's highest Days Inventory was 59.69. The lowest was 38.27. And the median was 47.09.
BOM:590006's Days Inventory is ranked better than 94.46% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs BOM:590006: 48.87
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amrutanjan Health Care's Inventory Turnover for the
three
months ended in Jun. 2026 was 1.45.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amrutanjan Health Care's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.36.
Amrutanjan Health Care (BOM:590006) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amrutanjan Health Care's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amrutanjan Health Care's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amrutanjan Health Care Days Inventory Related Terms
Amrutanjan Health Care Days Inventory Historical Data
* Premium members only.
The historical data trend for Amrutanjan Health Care's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amrutanjan Health Care Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amrutanjan Health Care's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amrutanjan Health Care (BOM:590006) has a Days Inventory of 62.79 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amrutanjan Health Care and its competitors. This is 33% above median its historical median of 47.09. Over the past decade, Amrutanjan Health Care's Days Inventory has ranged from 38.27 to 59.69. According to the industry distribution chart, Amrutanjan Health Care ranks #51 out of 921 companies in the Drug Manufacturers industry, placing it in the top 5.5%.
Is Amrutanjan Health Care's Days Inventory too high?
Amrutanjan Health Care's current Days Inventory of 62.79 is 33% above median its 10-year median of 47.09. Over the past 10 years, this metric has ranged from a low of 38.27 to a high of 59.69. The Drug Manufacturers industry median Days Inventory is 165.34. Amrutanjan Health Care's value of 62.79 is 62% below this industry median. Based on the distribution chart, Amrutanjan Health Care ranks #51 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Amrutanjan Health Care has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amrutanjan Health Care's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Amrutanjan Health Care ranks #51 out of 921 companies for Days Inventory. This places Amrutanjan Health Care in the top 6% of its industry — outperforming the majority of peers. The industry median Days Inventory is 165.34. Amrutanjan Health Care's value of 62.79 is 62% below this benchmark. Historically, Amrutanjan Health Care's own Days Inventory has ranged from 38.27 to 59.69 over the past decade. While the company's 10-year median is 47.09 vs. the industry median of 165.34, Amrutanjan Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amrutanjan Health Care's current Days Inventory of 62.79 is 62% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amrutanjan Health Care and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amrutanjan Health Care's current Days Inventory is 62.79, which is 33% above median its own 10-year median of 47.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amrutanjan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Amrutanjan Health Care (BOM:590006) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹827.69, compared to a current price of ₹490.35 — trading 40.8% below its estimated fair value. The current Days Inventory is 62.79, which is 33% above median its 10-year median of 47.09 and 62% below the Drug Manufacturers industry median of 165.34. Amrutanjan Health Care's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Amrutanjan Health Care (BOM:590006), the current Days Inventory is 62.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amrutanjan Health Care (BOM:590006) Overvalued in 2026?
Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued.
The current stock price of ₹490.35 is trading 40.8% below its estimated GF Value™ of ₹827.69.
GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:590006:
Days Inventory: 62.79 (33% above median its 10-year median of 47.09)
GF Value™: ₹827.69 vs. price of ₹490.35 (40.8% below fair value)
Industry Position: 62% below the Drug Manufacturers median (#51 of 921)
No single metric tells the full story. See the BOM:590006 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
71GF Score
Get the complete analysis for BOM:590006
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:590006 has been successfully added to your 
